EBV-Positive Mucocutaneous Ulcer

specific

A rare Epstein-Barr virus-positive B-cell lymphoproliferative disorder that affects mucosal sites (including oral mucosa, palate, tonsils, and gastrointestinal tract) and skin. It presents with well-circumscribed, often painful ulcers. It is associated with immune suppression, including age-related and drug-induced immunosuppression. In the majority of cases the lesions regress either spontaneously or following withdrawal of the immunosuppression therapy.

14

Centers

14

Active Trials

—

Cancer Funding

Top Centers for EBV-Positive Mucocutaneous Ulcer(14)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
Siteman Cancer CenterSt. Louis, MO
NCI Comprehensive
Active Research Program
53.6
2
Mayo Clinic Comprehensive Cancer CenterRochester, MN
NCI Comprehensive
Active Research Program
53.6
3
The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL
NCI Comprehensive
Active Research Program
53.6
4
Simmons Comprehensive Cancer Center UT Southwestern Medical CenterDallas, TX
NCI Comprehensive
Active Research Program
53.6
5
Laura and Isaac Perlmutter Cancer Center at NYU Langone HealthNew York, NY
NCI Comprehensive
Active Research Program
53.6
6
Moffitt Cancer CenterTampa, FL
NCI Comprehensive
Active Research Program
53.6
7
Roswell Park Comprehensive Cancer CenterBuffalo, NY
NCI Comprehensive
Active Research Program
53.6
8
The University of Arizona Cancer CenterTucson, AZ
NCI Comprehensive
Active Research Program
53.6
9
The University of Kansas Cancer CenterKansas City, KS
NCI Comprehensive
Active Research Program
53.6
10
Dartmouth Cancer CenterLebanon, NH
NCI Comprehensive
Active Research Program
53.6
11
University of Illinois Cancer CenterChicago, IL
Active Research Program
53.6
12
Cancer Center at IllinoisUrbana, IL
Active Research Program
53.6
13
Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL
Active Research Program
53.6
14
Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ
Active Research Program
53.6

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →